R

Rallybio Corp
D

RLYB

0.77000
USD
0.01
(1.13%)
مغلق
حجم التداول
263
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
31,945,441
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    BKNG
    BKNG
    -53.54
    (-1.06%)
    4,982.95 USD
    CCL
    CCL
    -1.335
    (-5.44%)
    23.220 USD
    E
    EXPE
    -8.300
    (-4.05%)
    196.800 USD
    HLT
    HLT
    -8.29
    (-3.10%)
    259.55 USD
    MAR
    MAR
    -9.88
    (-3.44%)
    277.48 USD
    N
    NCLH
    -1.555
    (-6.05%)
    24.130 USD
    RCL
    RCL
    -9.480
    (-3.89%)
    234.290 USD
    T
    TRIP
    -1.385
    (-8.39%)
    15.120 USD
    W
    WYNN
    -2.720
    (-2.91%)
    90.770 USD
    المزيد
الأخبار
المقالات

العنوان: Rallybio Corp

القطاع: Healthcare
الصناعة: Biotechnology
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.